ES2004395A6 - Procedimiento de obtencion de un sistema de vehiculo disolvente de doble fase, para compuestos farmaceuticamente activos. - Google Patents

Procedimiento de obtencion de un sistema de vehiculo disolvente de doble fase, para compuestos farmaceuticamente activos.

Info

Publication number
ES2004395A6
ES2004395A6 ES8700904A ES8700904A ES2004395A6 ES 2004395 A6 ES2004395 A6 ES 2004395A6 ES 8700904 A ES8700904 A ES 8700904A ES 8700904 A ES8700904 A ES 8700904A ES 2004395 A6 ES2004395 A6 ES 2004395A6
Authority
ES
Spain
Prior art keywords
carrier system
dual phase
solvent
phase solvent
solvent carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8700904A
Other languages
English (en)
Inventor
Marcel E Nimni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of ES2004395A6 publication Critical patent/ES2004395A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

PROCEDIMIENTO DE OBTENCION DE UN SISTEMA DE VEHICULO DISOLVENTE DE DOBLE FASE, PARA COMPUESTOS FARMACEUTICAMENTE ACTIVOS, CARACTERIZADO PORQUE COMPRENDE MEZCLAR A) DE 5 A 15% EN PESO APROXIMADAMEANTE DE UNO O MAS DISOLVENTES DE ADMINISTRACION; B) UNA CANTIDAD PRINCIPAL DE UNO O MAS DISOLVENTES FUGITIVOS; Y C) UN COMPUESTO FARMACEUTICAMENTE ACTIVO PARA FORMAR UNA SOLUCION DE ESTE ULTIMO EN DICHOS DISOLVENTES.
ES8700904A 1986-03-31 1987-03-31 Procedimiento de obtencion de un sistema de vehiculo disolvente de doble fase, para compuestos farmaceuticamente activos. Expired ES2004395A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/846,171 US4820724A (en) 1986-03-31 1986-03-31 Dual phase solvent carrier system

Publications (1)

Publication Number Publication Date
ES2004395A6 true ES2004395A6 (es) 1989-01-01

Family

ID=25297141

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8700904A Expired ES2004395A6 (es) 1986-03-31 1987-03-31 Procedimiento de obtencion de un sistema de vehiculo disolvente de doble fase, para compuestos farmaceuticamente activos.

Country Status (14)

Country Link
US (1) US4820724A (es)
EP (1) EP0261234B1 (es)
JP (1) JP2868768B2 (es)
KR (1) KR950008305B1 (es)
AU (1) AU601423B2 (es)
CA (1) CA1296630C (es)
DK (1) DK175632B1 (es)
ES (1) ES2004395A6 (es)
FI (1) FI90012C (es)
GB (1) GB2197788B (es)
GR (1) GR870502B (es)
HU (1) HU200912B (es)
IE (1) IE59892B1 (es)
WO (1) WO1987005806A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8805814D0 (en) * 1988-03-11 1988-04-13 Seton Prod Ltd Topical preparations
US6916486B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6998138B2 (en) * 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6929801B2 (en) * 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US7094422B2 (en) * 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6916487B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
WO2004000263A1 (en) 2002-06-25 2003-12-31 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
US7060303B2 (en) * 2002-12-31 2006-06-13 Avon Products, Inc. Use of purslane to treat facial wrinkles
US6866856B2 (en) * 2002-12-31 2005-03-15 Avon Products, Inc. Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
US7504385B2 (en) * 2003-12-17 2009-03-17 Avon Products, Inc. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US20100160244A1 (en) * 2004-09-02 2010-06-24 Marcel Nimni Methods and compositions for enhancing collagen, proteoglycan, and glutathione synthesis in the skin
US7598291B2 (en) * 2004-09-02 2009-10-06 Marcel Nimni Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
US7618662B2 (en) 2004-12-22 2009-11-17 Avon Products, Inc Use of natural plant extracts in cosmetic compositions
US7351745B2 (en) 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin
US7410658B2 (en) * 2004-12-22 2008-08-12 Avon Products, Inc. Use of Alisma orientale in cosmetics and compositions thereof
US7514092B2 (en) 2004-12-22 2009-04-07 Avon Products, Inc. Compositions and methods of their use for improving the condition and appearance of skin
GB0506141D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A topical compostion and its uses
GB0506139D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
DK1937276T3 (da) 2005-10-12 2013-02-11 Besins Healthcare Luxembourg Forbedret testosterongel og fremgangsmåde til anvendelse deraf
US7642062B2 (en) * 2006-12-29 2010-01-05 Avon Products Inc. Compositions and methods of their use for improving the condition and appearance of skin
NL2035417A (en) 2022-07-19 2024-01-26 Coty Inc Cosmetic composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1327853A (en) * 1971-05-24 1973-08-22 Ici Ltd Griseofulvin compositions
US4039664A (en) * 1975-04-11 1977-08-02 Nelson Research & Development Company Topical griseofulvin composition and method
JPS5636411A (en) * 1979-08-31 1981-04-09 Sumitomo Chem Co Ltd Liquid agent for external use
US4352808A (en) * 1980-12-12 1982-10-05 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(imidazolylmethyl)benzo(b)thiophenes and related derivatives, their use as antimicrobials and pharmaceutical formulations useful therefore
JPS57206610A (en) * 1981-06-12 1982-12-18 Lion Corp Anti-inflammatory analgesic solution for external use
JPS5815909A (ja) * 1981-07-22 1983-01-29 Toko Yakuhin Kogyo Kk 抗真菌外用剤
US4375474A (en) * 1982-02-11 1983-03-01 Syntex (U.S.A.) Inc. Dioxalane containing imidazole compounds, compositions and use
DE3233638A1 (de) * 1982-09-10 1984-03-15 Thilo & Co Gmbh Dr Dermatologische zubereitung
JPS59139325A (ja) * 1982-10-19 1984-08-10 Nissan Chem Ind Ltd 透明速乾性塗布剤組成物
JPS6016917A (ja) * 1983-07-08 1985-01-28 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンまたはニフエジピンの軟膏剤
US4912124A (en) * 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
FR2566661A1 (fr) * 1984-07-02 1986-01-03 Gendler El Methode pour dissoudre la griseofulvine en vue de preparer une solution de cette substance pour applications locales, qui soit chimiquement stable et douee d'activite biologique
JPS6169719A (ja) * 1984-09-13 1986-04-10 Kao Corp 外用抗真菌剤
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs

Also Published As

Publication number Publication date
GB8727799D0 (en) 1987-12-31
JPH01501145A (ja) 1989-04-20
IE59892B1 (en) 1994-04-20
WO1987005806A1 (en) 1987-10-08
FI875272A (fi) 1987-11-30
GB2197788B (en) 1990-05-09
DK626187A (da) 1988-01-25
IE870800L (en) 1987-09-30
AU601423B2 (en) 1990-09-13
HU200912B (en) 1990-09-28
AU7239187A (en) 1987-10-20
GB2197788A (en) 1988-06-02
JP2868768B2 (ja) 1999-03-10
FI90012C (fi) 1993-12-27
EP0261234B1 (en) 1991-05-15
DK175632B1 (da) 2004-12-27
GR870502B (en) 1987-06-10
FI90012B (fi) 1993-09-15
DK626187D0 (da) 1987-11-27
US4820724A (en) 1989-04-11
HUT49814A (en) 1989-11-28
KR950008305B1 (ko) 1995-07-27
EP0261234A4 (en) 1988-05-31
FI875272A0 (fi) 1987-11-30
EP0261234A1 (en) 1988-03-30
CA1296630C (en) 1992-03-03

Similar Documents

Publication Publication Date Title
ES2004395A6 (es) Procedimiento de obtencion de un sistema de vehiculo disolvente de doble fase, para compuestos farmaceuticamente activos.
GB8607159D0 (en) Pharmaceutical composition
AU7474187A (en) Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation
AU6866291A (en) Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
GR871817B (en) New pharmacologically active compounds,methods for the preparation thereof and compositions containing the same
MY109880A (en) Substituted biphenylpyridones
AU2332188A (en) Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
ZA878953B (en) New pharmacologically active compounds,methods for the preparation thereof and compositions containing the same
WO1989001342A3 (en) Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
WO1995001168A3 (de) Pharmazeutische zubereitungen, die einen wirkstoff mit modifizierten amidingruppen enthält
EP0249194A3 (en) Topical prostaglandin formulations
EG18379A (en) Novel pharmacological compounds
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
ATE278422T1 (de) Ascomycin enthaltende topische zubereitungen
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
DE3874610D1 (es)
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
CA2247198A1 (en) Topical pharmaceutical composition containing heparin
NO149961C (no) Fremgangsmaate for fremstilling av n-(2-hydroksyetyl)-derivater av makrocykliske polyaminer, inneholdende flere nitrogenatomer i 1,4-forhold i ringen
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
NZ336045A (en) Topical preparation containing a polypeptide, an epithelizing agent and capsaicine, histamine and/or cantharis extract
CA2015197A1 (en) Phenolic amine depigmenting and antimelanoma agents
ZA875790B (en) Imidazole compounds,processes for the preparation thereof and pharmaceutical composition comprising the same
EP0583606A3 (en) New cardioactive hydrazono-5-beta, 14-beta-androstanes, process for their preparation and the pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070402